KriyaBio offers innovative drug delivery solutions built around its proprietary permeation enhancer KB01. Our partners leverage our expertise to employ our unique paracellular drug transport mechanism to advance their early stage portfolio as well as to extend lifecycle for their existing products.
Being able to replace current intra-vitreal injection with eye drops represents a game changer for AMD treatment, a tremendous improvement of patient safety, patient compliance, and a severe relief on health care costs.
Increased patient compliance owing to simplicity
Early stage drug discovery & Portfolio Enrichment
Lower cogs & healthcare costs due to non-invasive formats versus injections
Want to understand a little more how we epithelial permeability is achieved using our proprietary enhancers? Check out the recent manuscript by Ragupathy, Brunner &